Research On Tax Planning Of Traditional Chinese Medicine Enterprises

Novel coronavirus pneumonia is a key part of the new type of coronavirus pneumonia in 2020.Chinese medicine has a very good performance,and the market prospect is broad.But the Chinese medicine manufacturers also have some problems at the same time.High.At present,the country has implemented a large-scale tax reduction and fee reduction policy.At the national level,there is little room to reduce the tax burden of enterprises.Tax planning,as an activity that has a significant impact on business operation,has a direct effect on reducing the cost of tax operation.If we want to further reduce the tax burden of enterprises and improve the profit level,we need enterprises to achieve this goal through tax planning.In this paper,combined with the national tax laws and policies,y pharmaceutical industry is taken as an example to study the tax planning scheme of traditional Chinese medicine enterprises,aiming to reduce the tax burden of enterprises,avoid tax risks and maximize the value of enterprises.Based on the basic theory of tax planning,this paper introduces the output value,market development and tax burden of traditional Chinese medicine industry.Then,according to the financial report and data of Y pharmaceutical industry,the basic situation of Y pharmaceutical industry is introduced,and its basic financial situation and tax burden are analyzed.On this basis,according to the classification of business work,the main tax related matters in the three basic activities of enterprise financing activities,investment activities and business activities are proposed one by one,or the tax risk is pointed out,and the planning effect of some different planning methods is analyzed by comparative analysis.The planning suggestions include adopting appropriate capital structure to raise funds,investing in setting up factories,choosing branches first,increasing indirect investment,choosing small-scale taxpayers as the taxpayers of Chinese herbal medicine suppliers within the group,adjusting the time of input tax certification,making use of upstream and downstream enterprises to transfer profits within a reasonable range,making reasonable use of R & D expenses plus deduction,and reminding the tax of environmental protection tax Risk collection,change of sales settlement method,multi agency sharing of advertising expenses and how to choose drug return and destruction,etc.Finally,it discusses the planning risks faced by Y pharmaceutical industry,mainly including internal risks such as management system risks,overall concept risks,cost-benefit risks,external risks such as macro environment change risks,tax laws and regulations change risks,and the legitimacy identification risks of both sides of the tax collection and payment,and puts forward corresponding avoidance measures for the above risks.The paper points out the basic operation space and risk points of the tax planning activities of the traditional Chinese medicine industry,and puts forward the planning plan combining with the specific situation and the latest policies,which can provide some reference suggestions for other traditional Chinese medicine enterprises operating similar businesses in the same industry.